1. Home
  2. CUE vs HUHU Comparison

CUE vs HUHU Comparison

Compare CUE & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • HUHU
  • Stock Information
  • Founded
  • CUE 2014
  • HUHU 2015
  • Country
  • CUE United States
  • HUHU China
  • Employees
  • CUE N/A
  • HUHU N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • HUHU
  • Sector
  • CUE Health Care
  • HUHU
  • Exchange
  • CUE Nasdaq
  • HUHU NYSE
  • Market Cap
  • CUE 91.9M
  • HUHU 86.2M
  • IPO Year
  • CUE 2018
  • HUHU 2024
  • Fundamental
  • Price
  • CUE $1.26
  • HUHU $4.00
  • Analyst Decision
  • CUE Strong Buy
  • HUHU
  • Analyst Count
  • CUE 5
  • HUHU 0
  • Target Price
  • CUE $5.00
  • HUHU N/A
  • AVG Volume (30 Days)
  • CUE 285.6K
  • HUHU 24.5K
  • Earning Date
  • CUE 03-10-2025
  • HUHU 02-22-2025
  • Dividend Yield
  • CUE N/A
  • HUHU N/A
  • EPS Growth
  • CUE N/A
  • HUHU 13.14
  • EPS
  • CUE N/A
  • HUHU 0.08
  • Revenue
  • CUE $9,532,000.00
  • HUHU $17,492,735.00
  • Revenue This Year
  • CUE $73.11
  • HUHU N/A
  • Revenue Next Year
  • CUE $11.02
  • HUHU N/A
  • P/E Ratio
  • CUE N/A
  • HUHU $48.67
  • Revenue Growth
  • CUE 149.53
  • HUHU 33.03
  • 52 Week Low
  • CUE $0.45
  • HUHU $3.52
  • 52 Week High
  • CUE $2.45
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • CUE 45.93
  • HUHU N/A
  • Support Level
  • CUE $1.20
  • HUHU N/A
  • Resistance Level
  • CUE $1.50
  • HUHU N/A
  • Average True Range (ATR)
  • CUE 0.12
  • HUHU 0.00
  • MACD
  • CUE -0.02
  • HUHU 0.00
  • Stochastic Oscillator
  • CUE 16.67
  • HUHU 0.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: